Where does Monash University rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Monash University ranks #3,137 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Monash University hold?

Monash University holds 120 US utility patents granted between 2015 and 2025, spanning 79 technology areas.

What is Monash University's Innovation Score?

Monash University has an Innovation Score of 58.1 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Monash University focus on?

Monash University's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 51 patents, ranking #346 of 6,058 assignees active in that subclass. Grants appear in 79 CPC subclasses total.

Is Monash University's patent grant rate increasing or decreasing?

Monash University's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Monash University's patents?

Monash University's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Monash University patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Monash University

USPTO PatentsView assignee record - 120 granted patents across 79 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Monash ranks #3,137 of 49,997 tracked US assignees by granted-patent volume, with 120 patents across 79 technology areas.

#3,137
of 49,997 US assignees by volume: Top 5%
by Innovation Score (58.1/100): 16.2
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3137 · Foreign Corporation #3,137 · 120 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 120 grants
TOP-DECILE #3,137/49,997
PHOTO-FINISH Guest Tek Interactiv…
CPC-WIDE A61P · 79 areas
INNOV-PAR 58.1/100
CLAIMS-RICH 16.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Guest Tek Interactive Entertainment Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Monash’s 58.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.6 pts (29%) Velocity 6.8 pts (12%) Breadth 25.0 pts (43%) Claim depth 9.7 pts (17%)

Qualcomm Incorporated · highest

85
Monash University · this assignee

58
VEO Robotics · near

58
xMEMS Labs · near

58
ZF Active Safety… · near

58
Roquette Freres · near

58
3D Lighting… · lowest

7

What this shows Monash's Innovation Score is 58.1/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Monash?

Each dot is one of Monash’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Monash’s own 16.2 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Monash vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Monash's grant cadence moved

Between 2020–2024, Monash University received 69 grants versus 46 in 2015–2019 (+50% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2021 at 15 grants and bottomed in 2016 at 5. Lead class A61P accounts for 42.5% of the portfolio across 79 subclasses. Volume neighbours: Guest Tek Interactive Entertainment Ltd. (#3,133) and Quantum-Si Incorporated (#3,141).

Monash's three-year grant acceleration

From 2019–2021 to 2022–2024, Monash University moved from 40 to 41 grants (1.02x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,117. See the growth leaderboard.

Guest Tek Interac…

120
Ixia

120
K-tronics (Suzhou…

120
Linak A/S

120
Mythical

120
North

120
Novaled

120
Quantum-si Incorp…

120
Monash University ◀

120

What this shows Monash holds 120 patents at rank #3,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Monash

By rank, the assignees closest to #3,137 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Monash's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Monash, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Monash ranks #346 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

xMEMS Labs, Inc. 58 VEO Robotics, Inc. 58 ZF Active Safety AND Electronics US LLC 58 Roquette Freres 58

Similar claim depth

Nearest assignees by average claims per patent (16.2 here).

Dresser, LLC 16.2 avg Optimedica Corporation 16.2 avg Straumann Holding AG 16.2 avg Huizhou China Star Optoelectronics Display Co., Ltd. 16.2 avg

Monash's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Monash University patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	10.0%
2016	5	4.2%
2017	7	5.8%
2018	10	8.3%
2019	12	10.0%
2020	13	10.8%
2021	15	12.5%
2022	15	12.5%
2023	13	10.8%
2024	13	10.8%
2025partial year	5	4.2%

Which technologies does Monash University patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 51

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 49

C07K - Peptides 24

Y02A - Technologies FOR Adaptation TO Climate Change 16

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 15

A61B - DIAGNOSIS; SURGERY; Identification 14

C07D - Heterocyclic Compounds 14

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 9

H01G - CAPACITORS; Capacitors, Rectifiers, Detectors, Switching Devices, Light-sensitive OR Temperature-sensitive Devices OF THE Electrolytic Type 7

C07C - Acyclic OR Carbocyclic Compounds 7

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 7

G06T - Image Data Processing OR Generation, IN General 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

Top 15 of 79 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Monash University's patent record in context - here's where to go next.

Monash University's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 42.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,137 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Monash University against Guest Tek Interactive Entertainment Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 58.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.